Alpha Teknova (NASDAQ:TKNO) Earns “Overweight” Rating from Stephens

Stephens restated their overweight rating on shares of Alpha Teknova (NASDAQ:TKNO) in a research report sent to investors on Wednesday, Benzinga reports. Stephens currently has a $5.00 target price on the stock.

Separately, BTIG Research downgraded shares of Alpha Teknova from a buy rating to a neutral rating in a research note on Tuesday, March 12th.

Alpha Teknova Stock Up 3.2 %

TKNO stock opened at $1.28 on Wednesday. The company has a quick ratio of 3.92, a current ratio of 5.52 and a debt-to-equity ratio of 0.16. Alpha Teknova has a one year low of $1.16 and a one year high of $4.27. The firm has a 50-day moving average of $1.62 and a two-hundred day moving average of $2.45.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings data on Monday, May 13th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.04. Alpha Teknova had a negative return on equity of 38.24% and a negative net margin of 97.85%. The firm had revenue of $9.29 million during the quarter, compared to the consensus estimate of $7.80 million. During the same period in the prior year, the business earned ($0.31) EPS. On average, research analysts expect that Alpha Teknova will post -0.65 EPS for the current year.

Institutional Investors Weigh In On Alpha Teknova

Several large investors have recently made changes to their positions in TKNO. State Board of Administration of Florida Retirement System acquired a new stake in Alpha Teknova in the first quarter valued at approximately $35,000. Fielder Capital Group LLC acquired a new stake in shares of Alpha Teknova in the 4th quarter valued at $156,000. FourWorld Capital Management LLC bought a new stake in Alpha Teknova in the first quarter worth $135,000. Redmile Group LLC increased its position in Alpha Teknova by 6.5% during the first quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock worth $434,000 after buying an additional 10,448 shares during the last quarter. Finally, Conestoga Capital Advisors LLC raised its holdings in Alpha Teknova by 4.1% during the fourth quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock valued at $923,000 after buying an additional 9,800 shares in the last quarter. Institutional investors own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.